The African Center for Translational Genetics (ACTG) is a not-for-profit entity with funding from 54gene Inc as part of its vision to democratize precision medicine. The objectives of the centre are to empower the next generation of African genomic scientists through the provision and implementation of grants, fellowships, and internships; enable better health outcomes by powering the discovery of disease variants which will significantly improve responses to drugs especially among African populations, and enhance therapy on the African continent by enabling individualized and precise care that utilizes patient unique genetic identity to develop new targets to medicine.

Application guideline:

1. Provide your personal statement (maximum 2 pages) addressing:

• Your past academic research and relevant work experience;
• Any involvement in broader impact activities relevant to the scope of 54gene, the ACTG and the NCD-GHS;
• Why you are interested in the ACTG Fellowship and how you envision it furthering your career;
• How your skills, expertise and networks can help drive forward, ACTG’s research projects, and the generation of insights from such projects to improve knowledge and healthcare for African populations

1. CV
2. One writing sample, and
3. Contact information for three references, with at least one reference who can speak to your broader impact activities.

Application deadline: 9th of November, 2020

About the ACTG

The ACTG is the African Centre for Translational Genomics. It is an entity designed by 54gene to facilitate precision medicine on the African continent, provide funding for translational genetics research by African scientists and re-invest in the health ecosystem by empowering the next generation of African genomic scientists through the provision and implementation of grants, internships and training for medical researchers and students.

About 54gene

54gene is a research, services and development company located in Nigeria and the United States. The company was founded in 2019 by Dr. Abasi Ene-Obong to improve our understanding of the world’s most genetically diverse population. 54gene utilises human genetic data from diverse African populations, to improve the development, availability and efficacy of medical products that will prove beneficial to Africans and the wider global population.

About NABDA

NABDAs vision is to promote biotechnological development initiatives that positively respond to national aspirations on food security, job/wealth creation, affordable healthcare delivery, and a sustainable environment.

The Centre for Genomics Research and Innovation (CGRI) was established by NABDA to help harness the potential of genomics science to improve food security, health care and sustainable development. Over the years, NABDA, through the CGRI has institutionalized capacity for translational genomics and bioinformatics training; through which it has identified various candidate drug molecules and training several Nigerians and other Africans in bioinformatics

About the NIMR

The Nigeria Institute of Medical Research is the pioneer health research institute in Nigeria that was established since 1977 to conduct research in diseases of public health importance in Nigeria.

About the NCD-GHS consortium

NCD-GHS Consortium is a partnership of Nigerian geneticists from 54gene, Nigeria Institute of Medical Research (NIMR), and the National Biotechnology Development Agency’s Centre for Genomics Research and Innovation (NABDA-CGRI). The consortium will study cardio-metabolic diseases, neurodegenerative diseases, cancers that are more prevalent on the African continent, endocrine disorders and Sickle Cell Disease.